Sign inJoin waitlistJoin the waitlist

Wendy Rhoades

Home Faculty & Staff Directory Wendy Rhoades · Texas Tech University Health Sciences Center at Lubbock

Credentials: · · · · · ·

History

Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present
Texas Tech University Health Sciences Center at Lubbock
Present

Pediatric Hematology/Oncology
Baylor College of Medicine
2010–2013
MedStar Georgetown University Hospital
2007–2010
Georgetown University School of Medicine
2003–2007
University of Nebraska
1999–2003

Research

Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 146 citations
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials
Review · Pediatric Blood & Cancer · 2022 · 109 citations
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
Review · Cancer · 2019 · 101 citations

Safia Ahmed
9 papers
Nadia Laack
8 papers
AM
Anita Mahajan
7 papers
Jason Yustein
6 papers
Nino Rainusso
6 papers
SP
Stephanie Polites
6 papers
Peter Rose
5 papers
Peter Schoettler
5 papers
Aaron Weiss
4 papers
DR
Damon Reed
4 papers
NH
Nate Hull
4 papers
Donald Parsons
3 papers

Clinical trials

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
Principal investigator · Active not recruiting · Phase 3
Children's Oncology Group
2021–2027
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2022–2030
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Site PI · Recruiting · Phase 1, Phase 2
PedAL BCU, LLC
2022–2030
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Site PI · Recruiting · Phase 2
Children's Oncology Group
2020–2027